Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pulmonx | LUNG | Jun 27, 2024 | 6.17 | +0.49 |
Pulse Biosciences | PLSE | Jun 27, 2024 | 11.01 | +10.43 |
PulteGroup | PHM | Jun 27, 2024 | 109.75 | -0.27 |
Puma Biotechnology | PBYI | Jun 27, 2024 | 3.23 | +2.87 |
Pure Cycle | PCYO | Jun 27, 2024 | 9.42 | +2.50 |
Pure Storage A | PSTG | Jun 27, 2024 | 65.18 | +3.94 |
PureCycle Technologies | PCT | Jun 27, 2024 | 5.99 | -0.99 |
PureCycle Technologies Unit | PCTTU | Jun 27, 2024 | 7.47 | 0.00 |
Purefunds ISE Junior Silver [Sm | SILJ | Jun 27, 2024 | 11.31 | +0.44 |
PureTech Health ADR | PRTC | Jun 27, 2024 | 24.50 | +3.03 |
Purple Biotech ADR | PPBT | Jun 27, 2024 | 0.44 | -8.83 |
Purple Innovation | PRPL | Jun 27, 2024 | 1.04 | +5.93 |
Putnam Managed Municipal Income Trust | PMM | Jun 27, 2024 | 6.15 | -0.16 |
Putnam Master Intermediate Income Trust | PIM | Jun 27, 2024 | 3.19 | +0.16 |
Putnam Municipal Opportunities Trust | PMO | Jun 27, 2024 | 10.20 | 0.00 |
Putnam Premier Income Trust | PPT | Jun 27, 2024 | 3.51 | -0.85 |
PVH | PVH | Jun 27, 2024 | 106.93 | -2.28 |
Pyrophyte Acquisition | PHYT | Jun 27, 2024 | 11.44 | 0.00 |
Pyxis Oncology | PYXS | Jun 27, 2024 | 3.21 | 0.00 |
Pyxis Tankers | PXS | Jun 27, 2024 | 5.03 | 0.00 |
Pyxis Tankers Pref | PXSAP | Jun 27, 2024 | 24.98 | +0.12 |
Q2 | QTWO | Jun 27, 2024 | 60.53 | +2.89 |
Q32 Bio | QTTB | Jun 27, 2024 | 15.25 | 0.00 |
QCR | QCRH | Jun 27, 2024 | 57.62 | +0.24 |
QIAGEN | QGEN | Jun 27, 2024 | 41.10 | +0.91 |
Qifu Technology ADR | QFIN | Jun 27, 2024 | 19.39 | -3.20 |
Qilian International | QLI | Jun 27, 2024 | 3.04 | -0.33 |
Qomolangma Acquisition | QOMO | Jun 27, 2024 | 11.05 | 0.00 |
Qorvo | QRVO | Jun 27, 2024 | 112.39 | -1.27 |
QT Imaging | QTI | Jun 27, 2024 | 0.75 | +2.23 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.